Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects

from oxidative stress-associated endothelial cell injury. by Migliori, M et al.
RESEARCH ARTICLE
Caffeic Acid, a Phenol Found in White Wine,
Modulates Endothelial Nitric Oxide
Production and Protects from Oxidative
Stress-Associated Endothelial Cell Injury
Massimiliano Migliori1☯*, Vincenzo Cantaluppi2☯, Claudio Mannari3, Alberto A. E. Bertelli4,
Davide Medica2, Alessandro Domenico Quercia2, Victor Navarro2, Alessia Scatena1,
Luca Giovannini3, Luigi Biancone2, Vincenzo Panichi1
1 Nephrology and Dialysis Unit, Versilia Hospital, Lido di Camaiore, Italy, 2 Nephrology, Dialysis and Kidney
Transplantation Unit, Department of Medical Sciences, University of Torino, Torino, Italy, 3 Department of
Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy, 4 Department of
Biomedical Sciences for Health, University of Milan, Milan, Italy




Several studies demonstrated that endothelium dependent vasodilatation is impaired in car-
diovascular and chronic kidney diseases because of oxidant stress-induced nitric oxide
availability reduction. The Mediterranean diet, which is characterized by food containing
phenols, was correlated with a reduced incidence of cardiovascular diseases and delayed
progression toward end stage chronic renal failure. Previous studies demonstrated that
both red and white wine exert cardioprotective effects. In particular, wine contains Caffeic
acid (CAF), an active component with known antioxidant activities.
Aim of the study
The aim of the present study was to investigate the protective effect of low doses of CAF on
oxidative stress-induced endothelial injury.
Results
CAF increased basal as well as acetylcholine—induced NO release by a mechanism inde-
pendent from eNOS expression and phosphorylation. In addition, low doses of CAF
(100 nM and 1 μM) increased proliferation and angiogenesis and inhibited leukocyte adhe-
sion and endothelial cell apoptosis induced by hypoxia or by the uremic toxins ADMA, p-
cresyl sulfate and indoxyl sulfate. The biological effects exerted by CAF on endothelial cells
may be at least in part ascribed to modulation of NO release and by decreased ROS pro-
duction. In an experimental model of kidney ischemia-reperfusion injury in mice, CAF signifi-
cantly decreased tubular cell apoptosis, intraluminal cast deposition and leukocyte
infiltration.
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Conclusion
The results of the present study suggest that CAF, at very low dosages similar to those ob-
served after moderate white wine consumption, may exert a protective effect on endothelial
cell function by modulating NO release independently from eNOS expression and phos-
phorylation. CAF-induced NOmodulation may limit cardiovascular and kidney disease pro-
gression associated with oxidative stress-mediated endothelial injury.
Introduction
Nitric oxide (NO) is a potent vasodilator, involved in the regulation of vascular homeostasis.
NO inhibits platelet aggregation and adhesion, leukocyte—endothelial cell interaction and
smooth muscle cell proliferation and migration [1,2]. In the last years, several studies demon-
strated that endothelium-dependent vascular relaxation is reduced in various diseases, such as
diabetes, heart failure, coronary heart disease (CHD), hypertension, atherosclerosis and chron-
ic kidney disease (CKD). In these pathologic conditions, NO bioavailability is reduced by oxi-
dation due to excessive production of superoxide anions in the vascular wall, suggesting that
antioxidant compounds may have a role in the modulation of endothelial-dependent vasodila-
tation [3–5].
Epidemiological studies reported that a diet enriched in vegetables and fruits may contribute
to reduce the incidence of cancer and cardiovascular disease [6,7]. In particular, a significant
reduction in the incidence of CHD was observed in certain areas of France where fat intake is
high, leading to the concept of the “French paradox” [8]. The Mediterranean diet, which is
characterized by food containing phenols, was also correlated with a reduced incidence and de-
layed progression of CKD [9,10]. Further studies evidenced a protective effect of dietary intake
of phenols contained in red [11,12] or white wine [13–15], and olive oil [16,17]. It has been re-
ported that wine-derived phenols may reduce endothelial dysfunction by enhancing NO avail-
ability and/or generation [18–20]. Oral administration of red wine polyphenolic compounds
decreased blood pressure in hypertensive rats. This hemodynamic effect was associated with an
enhanced endothelium-dependent relaxation and stimulation of inducible NO synthase and
cyclooxygenase 2 gene expression within the arterial walls [21]. The cardioprotective activity of
red wine has been ascribed mainly to phytocomplex rich in polyphenols, in particular resvera-
trol (RSV). However, several reports indicated that also white wine may exert cardiovascular
protective effects despite the very low content of RSV [22–25]. White wine contains phenols
with antioxidant properties such as Caffeic Acid (CAF) and Tyrosol (TYR). In particular, Pra-
sad and co-workers [26] reported that CAF significantly reduced lipid peroxidation and de-
creased DNA damage in UVB-irradiated lymphocytes. Furthermore, CAF pre-treatment
significantly maintains antioxidant status and decreased UVB-induced cytotoxicity[26]. More-
over, Khan et al. [27,28] demonstrated that CAF can reduce oxidative stress and inflammation
induced by 12-O-tetradecanoyl-phorbol-13-acetate in vivo. However, the effect of these com-
pounds on NO production has not been extensively investigated.
The aim of the present study was to evaluate whether low doses of CAF comparable to those
assumed with moderate white wine consumption may exert a protective effect on endothelial
injury induced by hypoxia and uremic toxins.
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Materials and Methods
Human Endothelial Cell Culture
Human umbilical vein-derived endothelial cells (HUVEC) were obtained by ATCC (PCS-100-
010—ATCC USA). HUVECs were plated onto flask with EBMmedium supplemented with
10% fetal calf serum and different endothelial growth factors as previously reported [29].
HUVECs were cultured for 24 h into an airtight humidified chamber flushed with a gas
mixture containing 5% CO2, 94% N2, and 2% O2 at 20 atm, 37°C [30] or with the uremic toxins
asymmetric dimethylarginine (ADMA 10 μg/ml from Sigma Aldrich, St. Louis, MO), p-cresyl
sulfate (1 μg/ml from Alsachim, Illkirch Graffenstaden, France) and indoxyl sulfate (10 μg/ml
from Sigma Aldrich, St. Louis, MO).
Analysis of NO generation by endothelial cells stimulated with L-Arginine
and Acetylcholine
NO generation by HUVECs was detected in chemiluminescence, as previously described [31–
32] with some modification. Briefly, HUVECs were cultured in luminometer cuvettes coated
with gelatin in appropriate medium and incubated overnight (o.n.) with TYR 100 nM and 1 μM,
CAF 100 nM and 1 μM. L-Arginine 1 mM and L-NAME 1 mMwere used as positive and nega-
tive controls, respectively. At the end of each experiment, culture medium was removed and
substituted with HEPES-buffered Krebs medium containing 0.5% BSA, luminol 100 μM (Sigma
Aldrich) and hydrogen peroxide (H2O2) 100 nM; then the cuvettes were inserted into a Lumin-
ometer (Berthold, Germany). Baseline chemiluminescence was recorded for 60 seconds and ex-
pressed as mean value. Then the cells were stimulated with Ach 100 μM and chemiluminescence
was recorded continuously for 180 seconds. Results were expressed as relative light unit (RLU).
Quantification of NO generation by the fluorescent probe DAF-2 DA
The cell-permeable NO reactive dye, diaminofluorescein 2 diacetate (DAF-2 DA, Alexis Italia/
Biochem, Vinci, Italy) was used to examine baseline production of NO in HUVECs plated on
gelatin-coated glass-plastic dishes, as previously reported [33].
Cells were washed three times with PBS and were then loaded with DAF-2 DA and/or the
phenols at the concentration reported above. Immediately before use, DAF-2 DA stock solu-
tion (5 mM) was diluted to a final concentration of 5 μM in PBS-BSA 0.25% (working solu-
tion). As control of the eNOS inhibitory activity, HUVECs were incubated with L-NAME for
30 minutes and then with CAF and TYR for 30 minutes.
HUVECs were incubated for 60 min at 37°C within 1 mL/well of the working solution con-
taining L-Arginine (L-Arg) or the phenols and then transferred to a Diaphot inverted micro-
scope (Nikon, Melville, NY) with 20× fluorescent objective in an attached, hermetically sealed
Plexiglas NP-2 incubator (Nikon) at 37°C. The microscope was equipped with a video camera
connected (Leica, Deerfield, IL) to an IBM-compatible computer. The exposure time was 1.76
sec. Sequential exposures of the same microscopic field were acquired. Image analysis was per-
formed with MicroImage analysis system (Cast Imaging, Venice, Italy). L-NAME 1mM was
used as negative control. Quantification of fluorescence intensity was performed by FACS anal-
ysis after DAF-2 DA incubation as described below in more details. Experiments were con-
ducted in triplicate.
FACS Analysis
For FACS analysis, HUVECs were subjected to fixation and permeabilization with 1xPBS con-
taining-1% paraformaldehyde and 0.1% Triton-X, detached with EDTA and stained for 1 h at
Caffeic Acid Modulates Nitric Oxide Production
PLOS ONE | DOI:10.1371/journal.pone.0117530 April 8, 2015 3 / 21
4°C with primary antibodies directed to human Akt, P-Akt, eNOS or P-eNOS (Santa Cruz Bio-
tech, Santa Cruz, CA) or with an irrelevant control antibody. After extensive washing, cells
were incubated with appropriate Alexa Fluor—conjugated secondary antibodies for 45 min at
4°C. All incubation periods were performed using a medium containing 0.25% BSA and
0.0016% sodium azide. At the end of staining, cells were newly washed, fixed in, and subjected
to FACS analysis (Becton Dickinson, Mountain View, CA). Results are expressed as ratio be-
tween P-Akt/Akt and P-eNOS/eNOS percentage of positivity.
ROS production: Lucigenin-enhanced chemiluminescence
Superoxide (O2_
-) production was revealed by chemiluminescence in presence of lucigenin, as
previously described with some modifications [34]. Briefly, HUVECs were cultured in lumin-
ometer cuvettes coated with gelatin in appropriate medium, and incubated overnight with RSV
100 nM and 1 μM, TYR 100 nM and 1 μM, CAF 100 nM and 1 μM. At the end of each experi-
ment, culture medium was removed and substituted with HEPES-buffered Krebs medium con-
taining 0.5% BSA and lucigenin 250 μM (Sigma Aldrich). HUVECs were stimulated with the
calcium ionophore A23187 (Sigma Aldrich), and the chemiluminescence generated was con-
tinuously monitored using a Berthold Luminometer (Germany) for 5 minutes. Results were ex-
pressed as mean relative light unit (RLU).
Image-iT LIVE Green Reactive Oxygen Species (ROS) Detection Kit
Image-iT LIVE Green Reactive Oxygen Species (ROS) Detection Kit was used to analyze oxida-
tive stress on HUVECs as suggested by manufacturer (Life Technologies). Briefly, 5-(and-6)-
carboxy-2',7'-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) was added to HUVECs
in different experimental conditions: after 30 min, cells were fixed with 4% paraformaldehyde
and then counterstained with Hoechst and analyzed by Immunofluorescence or FACS analysis.
In selected experiments, the protective effect of CAF on HUVEC cultured under hypoxic
condition or in presence of uremic toxins was also evaluated.
Cytotoxicity assay—XTT assay
HUVECs were cultured on 24-well plates (Falcon Labware, Oxnard, CA) at a concentration of
5 × 104 cells/well and incubated for 24h with increasing doses of CAF (Sigma Aldrich) in nor-
moxic, hypoxic culture condition or in presence of uremic toxins. Cells were then incubated
with a medium without phenol red additioned with 250 μg/ml XTT (Sigma Aldrich). The ab-
sorption values at 450 nm were measured in an automated spectrophotometer at different time
points. All experiments were performed in triplicate.
Detection of apoptosis—TUNEL assay
HUVECs were incubated for 24h with increasing concentrations of CAF (Sigma Aldrich) in
normoxia, hypoxia or uremic toxins and then subjected to terminal deoxynucleotidyltransfera-
semediated dUTP nick end labelling (TUNEL) assay (ApopTag, Oncor, Gaithersburg, MD)
that identifies DNA fragmentation, a typical feature of apoptotic cells. Green-stained apoptotic
cells were counted in 10 different microscopic fields at ×100 magnification for each experimen-
tal point. All experiments were performed in triplicate.
PBMC Adhesion to HUVECmonolayers
PBMC adhesion to HUVEC monolayers was performed as previously described [35]. PBMC
were collected from healthy volunteers using samples obtained by the local blood bank (Banca
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del Sangue, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino) and
discarded from clinical use. A written informed consent was obtained from all subjects in ac-
cordance with blood bank guidelines. PBMCs were isolated from healthy volunteers by density
gradient and labelled with 10 μmVybrant cell tracer (Life Technologies, Carlsbad, CA).
PBMCs (50 × 106/ml) were added to HUVEC monolayer previously incubated with increasing
concentrations of CAF in normoxic, hypoxic condition or in presence of uremic toxins for 12h.
After extensive washing to remove detached PBMCs, green-stained cells adherent to HUVEC
monolayers were counted in 10 different microscopic fields at ×100 magnification for each ex-
perimental point. All experiments were performed in triplicate.
In vitro angiogenesis on Matrigel
The in vitro property of HUVECs to form capillary-like structures was studied culturing
HUVECs (5 × 104 cells/well) on growth factor—reduced Matrigel (Becton Dickinson. St. Jose,
CA) diluted 1:1 in ice with cold DMEM (Sigma, St.Louis, MO—USA) [36]. After extensive
washing, different concentrations of CAF were added to HUVECs cultured in normoxia, hyp-
oxia or in presence of uremic toxins. Cells were observed under a Nikon-inverted microscope
(Nikon, Kanagawa, Japan). Image analysis was performed with the MicroImage analysis system
(Casti Imaging, Venice, Italy)[31].
Gene array analysis
Human GEarray kit for the study of angiogenesis markers (SuperArray Inc., Bethesda, MD)
was used to characterize the gene expression profile of HUVECs cultured under hypoxic condi-
tion in presence or absence of 1 μMCAF for 24h. RNA extraction and retro-transcription of
total RNA were performed using a commercial kit as suggested by manufacturer (SuperArray).
Microarray data were deposited on European Bioinformatic Institute (EBI) website (www.ebi.
ac.uk/microarray-as/ae/; experiments archive code: E-MEXP-3908).
Experimental model of kidney ischemia-reperfusion injury in C57BL-6
mice
C57BL-6 mice were anesthetized by using an induction chamber with isoflurane and by intra-
peritoneal administration of ketamine (100 mg/kg). Right renal artery and vein were occluded
by using a non-traumatic vascular clamp for 30 min. Animals were divided in the following
groups: 1) Sham-operated; 2) Ischemia-reperfusion injury (right renal pedicle clamp); 3) Ische-
mia-reperfusion injury + Caffeic acid (right renal pedicle clamp + 1μM/ml CAF). Six animals
from each group were sacrificed 24 hr after renal pedicle clamp. For renal histology, 5-mm-
thick paraffin kidney sections were stained with hematoxylin/eosin (Merck, Darmstadt, Ger-
many). Luminal hyaline casts and cell loss (denudation of tubular basement membrane) were
assessed in 30 non-consecutive fields using a x40 objective (high-power field: HPF). TdT-
mediated dUTP nick end labelling assay (Chemicon International, Temecula, CA) for the detec-
tion of apoptotic cells was performed according to manufacturer’s instructions. Granulocyte in-
filtration was evaluated by staining with an anti-granulocyte antibody (Serotec, Oxford, UK) and
immunoperoxidase staining was performed by using an anti-rat HRP (Pierce, Rockford, IL).
Statistical analysis
All data of different experimental procedures are expressed as average±1SD. Analysis of vari-
ance (ANOVA) and Student-Newman-Keuls analysis were used as statistical test where
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appropriated. For all experiments performed by FACS, Kolmogorov Smirnov statistical analy-
sis was performed. For all analysis, a p value<0.05 was considered statistical significant.
Results
Quantification of NO release by chemiluminescence
Ach stimulation increased NO production by HUVECs in respect to baseline. Chemilumines-
cence decreased at every time point recorded even though at the end of observation (180 sec)
remained higher than in unstimulated cells (Fig. 1A-B). However, TYR and CAF induced dif-
ferent responses in HUVECs: 100nM and 1μMTYR did not affect Ach-induced NO release
(Fig. 1A). By contrast, CAF enhanced Ach-induced NO release in a dose-dependent manner
(Fig. 1B). CAF-induced NO production remained at plateau for 25 sec., with a subsequent de-
crease. We then evaluated in HUVECs the effect of different phenols on NO production inde-
pendent by Ach stimulation (Fig. 2). L-Arg and L-NAME were used as positive and negative
Fig 1. Ach induced NO production by HUVECs. Ach stimulation increased NO release, revealed by
chemiluminescence. TYR 1μM and 100nM did not affect Ach-induced NO release (Fig. 1A); CAF enhanced
Ach-induced NO release in a dose-dependent manner (Fig. 1B) (p<0.05 CAF vs. controls or vs. Ach at all
time points considered). Results are expressed as average±1SD of 6 different experiments.
doi:10.1371/journal.pone.0117530.g001
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controls, respectively. NO-generated chemiluminescence confirmed the lack of effect of TYR,
whereas CAF increased NO production in a dose-dependent manner (Fig. 2).
Quantification of NO release by the fluorescent probe DAF-2 DA
NO baseline production by HUVECs was also evaluated by quantitative fluorescence emission
generated by DAF-2 DA oxidation. L-Arg but not L-NAME stimulated fluorescence emission
that peaked at 30 min (Fig. 3A). The analysis of fluorescence intensity showed a significant in-
crease in DAF-2 DA oxidation in respect to L-Arg after incubation with CAF 100nM or 1μM
(Fig. 3B) in a dose dependent manner. TYR did not affect NO baseline production.
Evaluation of eNOS expression and phosphorylation
FACS analysis of HUVECs incubated overnight with TYR and CAF did not show any differ-
ences in eNOS and Akt expression and phosphorylation when compared to controls stimulated
with vehicle alone (Fig. 4).
ROS production
The production of ROS was evaluated by enhancement of lucigenin chemiluminescence.
HUVECs incubated with A23187 significantly increased ROS production compared to cells
challenged with vehicle alone. CAF and TYR significantly inhibited A23187-induced ROS pro-
duction, suggesting an antioxidant activity (Fig. 5).
Quantification of NO release and ROS expression in HUVECs cultured
in hypoxia or in presence of uremic toxins
In selected experiments, the protective effect of CAF was evaluated on HUVECs cultured
under hypoxic condition or in presence of uremic toxins.
Hypoxia or the uremic toxins ADMA, p-cresyl sulfate and indoxyl sulfate reduced NO re-
lease from HUVECs as shown by immunofluorescence studies (Fig. 6A) and FACS analysis
Fig 2. NO-generated chemiluminescence by HUVECs incubated overnight with the phenols.
L-Arginine 1 mM and L-NAME 1 mMwere used as positive and negative controls, respectively. CAF
increased NO production in a dose-dependent manner (*p<0.05 vs controls and L-NAME; § p<0.05 vs CAF
100 nM; # p<0.01 vs controls). Results are expressed as average±1SD of 6 different experiments.
doi:10.1371/journal.pone.0117530.g002
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(Fig. 6B) using the DAF-2 DA probe. By contrast, CAF 1μM restored NO release from
HUVECs cultured in hypoxia or with uremic toxins (Fig. 6A-B).
In addition, hypoxia as well as uremic toxins increased ROS production in HUVECs as
shown by immunofluorescence studies (Fig. 7A) and FACS analysis (Fig. 7B) using the Image-
iT LIVE Green Reactive Oxygen Species (ROS) Detection Kit. CAF 1μM significantly decreased
hypoxia- and uremic toxin-induced ROS production by HUVECs (Fig. 7A-B).
CAF induced proliferation and resistance to apoptosis, reduced
leukocyte adhesion and stimulated angiogenesis of HUVECs cultured
under hypoxia or in presence of uremic toxins
Increasing doses of CAF (100 nM, 1μM, 10μM) significantly increased proliferation (Fig. 8A),
and reduced apoptosis (TUNEL assay in Fig. 8B). In addition, 1μMCAF significantly reduced
PBMC adhesion to HUVEC monolayers cultured under hypoxia, suggesting an anti-inflamma-
tory effect (Fig. 8C). CAF also triggered angiogenesis of hypoxic HUVECs as shown in repre-
sentative micrographs (Fig. 8D) and in count of capillary-like structure formation (Fig. 8E) on
Matrigel-coated plates. To further confirm the pro-angiogenic effect of CAF on hypoxic
Fig 3. DAF-2 DA detected fluorescence. A) L-Arg stimulated fluorescence emission which peaked at 30
min (*p<0.01 vs controls). L-NAME was utilized as negative control (§p<0.05 vs L-Arg). B) CAF 100 nM and
CAF 1 μM enhanced NO dependent fluorescence (*p<0.01 vs controls). CAF 1 μM induced NO release was
significantly (#p<0.05) higher in respect to CAF 100 nM. Results are expressed as average±1SD of 6
different experiments.
doi:10.1371/journal.pone.0117530.g003
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HUVEC, we performed gene array analysis: we found that CAF up-regulated in hypoxic
HUVECs the expression of several genes involved in angiogenesis, cell proliferation and resis-
tance to apoptosis (Fig. 9). A similar protective effect of CAF on proliferation (Fig. 10A), resis-
tance to apoptosis (Fig. 10B), PBMC adhesion (Fig. 10C) and triggering of angiogenesis
(Fig. 10D-E) was also observed in HUVECs cultured in presence of the uremic toxins ADMA,
p-cresyl sulfate and indoxyl sulfate known to induce endothelial injury and apoptosis through
the induction of oxidative stress [37–40].
CAF reduced tubular injury and granulocyte infiltration after kidney
ischemia-reperfusion injury
In comparison to sham-operated animals, mice subjected to kidney ischemia-reperfusion inju-
ry showed histological signs of tubular injury such as formation of hyaline casts, vacuolization,
Fig 4. Evaluation of eNOS activation by FACS in HUVECs. Histograms show the ratio between P-eNOS/
eNOS and P-Akt/Akt in HUVECs incubated with vehicle alone or with TYR 1μM and CAF 1μM. Results are
expressed as ratios of P-eNOS/eNOS and P-Akt/Akt derived from a single FACS experiment. Three different
experiments were performed with similar results.
doi:10.1371/journal.pone.0117530.g004
Fig 5. Superoxide production revealed by lucigenin enhanced chemiluminescence in HUVECs
incubated with the different phenols and stimulated with the calcium ionofore A23187.CAF and TYR
significantly inhibited A23187-induced ROS production (*p<0.001 vs controls, § p<0.01 vs A23187). Results
are expressed as average±1SD of 6 different experiments.
doi:10.1371/journal.pone.0117530.g005
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diffuse necrosis and denudation of basal membrane. When mice were treated with 1μM/ml
CAF, a significant reduction of tubular injury was observed (Fig. 11A and Table 1). In addition,
CAF significantly reduced the number of apoptotic tubular cells (Fig. 11B) and granulocyte in-
filtration (Fig. 11C) within ischemic kidney.
Fig 6. CAF increased NO production by HUVECs cultured in hypoxia or with uremic toxins.
Representative fluorescence micrographs (A) and FACS analysis (B) of DAF-2DA probe on HUVECs
cultured in hypoxia or with uremic toxins in presence or absence of CAF 1 μM. For immunofluorescence
studies, magnification was x400; for FACS analysis, Kolmogorov-Smirnov statistical analysis was performed.
For all assays, 5 independent experiments were performed with similar results.
doi:10.1371/journal.pone.0117530.g006
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Discussion
In the present study, we demonstrated that CAF modulates endothelial NO production in a
dose-dependent manner. These results may suggest a potential role of CAF in the inhibition of
oxidant stress-associated endothelial dysfunction induced by hypoxia or by incubation with
the uremic toxins ADMA, p-cresyl sulfate and indoxyl sulfate. This potential protective effect
of CAF was confirmed in an experimental model of kidney ischemia-reperfusion injury in
which this compound significantly reduced tubular cell apoptosis and granulocyte infiltration.
We first observed that CAF induced an enhancement of basal and Ach-induced NO pro-
duction by HUVECs. This effect was not due to an increased expression of eNOS but rather to
a scavenger. activity of CAF. Indeed, we did not observe an increased phosphorylation of eNOS
in endothelial cells treated with CAF, suggesting that NO production was not directly
Fig 7. CAF decreased ROS expression in HUVECs cultured in hypoxia or with uremic toxins.
Representative fluorescence micrographs (A) and FACS analysis (B) of the Image-iT LIVE Green Reactive
Oxygen Species (ROS) Detection Kit on HUVECs cultured in hypoxia or with uremic toxins in presence or
absence of CAF 1 μM. For immunofluorescence studies magnification was x200; for FACS analysis,
Kolmogorov-Smirnov statistical analysis was performed. For all assays, 5 independent experiments were
performed with similar results.
doi:10.1371/journal.pone.0117530.g007
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Fig 8. CAF induced proliferation and resistance to apoptosis, decreased PBMC adhesion and
triggered in vitro angiogenesis of hypoxic HUVECs. Proliferation (XTT-based assay in A), resistance to
apoptosis (TUNEL assay in B), PBMC adhesion (C) and in vitro angiogenesis on Matrigel coated-plates
(representative micrographs in D, count of capillary-like structures in E) of HUVECs cultured in hypoxia in
presence or absence of CAF. Hypoxia reduced cell viability, increased apoptosis and PBMC adhesion and
Caffeic Acid Modulates Nitric Oxide Production
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stimulated by this compound. Furthermore, the experiments performed with the pro-oxidant
A23187 confirmed the anti-oxidant and scavenger activity of CAF.
Previous studies demonstrated that CAF has a potential anti-atherogenic activity through
the reduction of cell adhesion molecule expression and chemokine production by HUVECs in-
cubated with inflammatory cytokines such as TNF-α [41]. In the present study, we demon-
strated that CAF, at doses comparable with those observed after moderate white wine
consumption [42–43], induced NO production in endothelial cells [28, 42, 44, 45]. The efficacy
of CAF in modulating NO metabolism has also been recently confirmed in an experimental
model of cerebral infarction in adult male New Zealand rabbits [46]. These results are in accor-
dance with previous studies showing CAF-induced vasorelaxation in isolated rat aorta [47],
whereas other phenols such as TYR were ineffective [48]. TYR is an extensively investigated
phenol present in wine and olive oil, main components of the Mediterranean diet. TYR is
known to exert anti-oxidant activities in different in vitro studies and experimental models
[48]. Our results confirmed the anti-oxidant properties of TYR. However, TYR was less effec-
tive than CAF in NO production by HUVECs, suggesting that CAF may be one of the key me-
diators involved in the reduction of endothelial dysfunction observed in subjects adherent to
Mediterranean diet [49].
The typical endothelial dysfunction could be ascribed either to eNOS inhibition or to an in-
creased superoxide production [50]. In our experiments, the increase of endothelial NO bio-
availability induced by CAF was not due to an enhancement of eNOS expression but rather to
an anti-oxidant activity in accordance with previous studies [51]. Basing on these observations,
we investigated the protective effect of CAF on oxidant stress-induced endothelial dysfunction
in two different in vitromodels using HUVECs cultured under hypoxia or with known uremic
toxins such as ADMA, p-cresyl sulfate and indoxyl sulfate. Indeed, hypoxia as well as uremic
toxins plays a crucial role in CKD progression through a pro-inflammatory, pro-apoptotic and
anti-angiogenic activity on endothelial cells [52].
We observed that increasing doses of CAF reduced the cytotoxic and pro-apoptotic effect
induced by hypoxia on HUVECs. Moreover, CAF significantly reduced the adhesion of leuko-
cytes on hypoxia-stimulated HUVEC monolayers, suggesting a role in the inhibition of the in-
flammatory endothelial response typical of ischemia-reperfusion injury [53]. Indeed, in the
present study, we found that in an experimental model of acute kidney injury (AKI) due to is-
chemia-reperfusion, CAF significantly reduced the percentage of tubular cell apoptosis as well
as the number of infiltrating granulocytes. These results suggest a dual protective role of CAF
on hypoxia-associated tubular injury and inflammation.
Ischemic-induced tissue hypoxia is a condition shared by different pathologic conditions as-
sociated with endothelial dysfunction including AKI, CHD and CKD [53]. Indeed, it has been
shown that alteration of oxygen pathways and NO play a key role in the pathogenesis of acute
kidney injury (AKI) and in the cellular mechanisms of progression toward CKD [54]. In partic-
ular, chronic hypoxia in the renal tubulo-interstitial compartment is responsible for the hemo-
dynamic changes and for the altered oxygen metabolism of resident kidney cells that lead to
the typical histological findings of CKD such as peritubular capillary rarefaction, tubular atro-
phy and interstitial fibrosis [55]. Hypoxia causes endothelial apoptosis and promotes epitheli-
al-to-mesenchymal transition through the increased expression of extracellular matrix proteins
abrogated angiogenesis of HUVECs (#p< 0.05 Hypoxia vs. Normoxia). By contrast, increasing doses of
CAF (100 nM, 1μM, 10μM) increased viability and resistance to apoptosis (*p< 0.05 Hypoxia + CAF 100 nM,
1μM or 10μM vs. Hypoxia), and a fixed dose of CAF 1μM decreased PBMC adhesion and triggered
angiogenesis of hypoxic HUVECs (*p< 0.05 Hypoxia + CAF 1μM vs. Hypoxia). Results are expressed as
average±1SD of 3 different experiments.
doi:10.1371/journal.pone.0117530.g008
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Fig 9. Modulation of gene array profiling of hypoxic HUVECs induced by CAF 1μM (angiogenesis-
related genes). The graph shows the fold variation of angiogenesis-related genes between HUVECs
stimulated with Hypoxia + CAF 1μM vs. Hypoxia in a single experiment. Samples were normalized for the
signals found in housekeeping genes [actin, glyceraldehyde 3 phosphate dehydrogenase (GAPDH)]. Three
independent experiments were performed with similar results. Gene table: AKT1, V-akt murine thymoma viral
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and oxidative genes [56]. Moreover, it has been shown that uremia induces an alteration of ox-
ygen consumption in kidney resident cells leading to the deterioration of renal function
through oxidative stress [55–56]. Our results suggest a protective effect of CAF in the course of
events leading to oxidative stress-induced endothelial injury and CKD progression in presence
of hypoxia. In addition, it has been shown that several uremic toxins, biologically active uremic
retention molecules known to accelerate renal dysfunction, are able to deregulate oxygen me-
tabolism, thus worsening the hypoxic damage and the activation of the renin-angiotensin-
aldosterone system [57]. Among uremic toxins, guanidino compounds are known to induce
endothelial production of ROS, cytotoxicity and calcification [58]. Asymmetric dimethylargi-
nine (ADMA) is a key mediator of uremia-associated endothelial dysfunction and triggering of
atherosclerosis. ADMA is an endogenous L-arginine analogue acting as inhibitor of NO
synthase whose levels are significantly increased in end stage renal disease patients. In addition,
elevated ADMA levels are associated with an enhancement of CKD progression and with an
increased incidence of cardiovascular and cerebrovascular diseases due to oxidative stress dam-
age [59]. Other protein bound uremic toxins such as p-cresyl sulfate and indoxyl sulfate are in-
creased in uremic patients and are known to induce an intense production of ROS and
senescence of endothelial cells [60]. Moreover, indoxyl sulfate inhibits NO production and fa-
cilitate leukocyte endothelial interaction through the up-regulation of E-selectin, ICAM-1 and
MCP-1 on endothelial cell surface [61]. A similar effect of indoxyl sulfate as well as of p-cresyl
sulfate has also been observed on kidney tubular epithelial cells through ROS production, acti-
vation of NF-kB and p53 and production of TGF-beta able to enhance the epithelial-to-
mesenchymal transition [62]. As described for hypoxia-induced damage, we found that CAF,
at low doses present in the white wine, protected endothelial cells from apoptosis and function-
al alterations induced by ADMA, p-cresyl sulfate and indoxyl sulfate at levels found in the ure-
mic milieu. In particular, CAF increased cell proliferation, resistance to apoptosis and in vitro
angiogenesis that were all reduced after treatment with uremic toxins. In addition, CAF signifi-
cantly reduced the adhesion of leukocyte to HUVECs incubated with uremic toxins.
CAF-associated endothelial protection was mainly ascribed to the inhibition of ROS expres-
sion and to the increase of NO release. However, gene array analysis revealed that CAF was
able to modulate the endothelial expression of several genes involved in angiogenesis and inhi-
bition of apoptosis of hypoxic endothelial cells independently by NO production. In particular,
CAF induced the endothelial expression of different growth factors and angiogenic molecules
oncogene homolog 1; ANGPT1, Angiopoietin 1; ANGPTL3, Angiopoietin-like 3; ANGPTL4, Angiopoietin-like
4; BAI1, Brain-specific angiogenesis inhibitor 1; CDH5, Cadherin 5, type 2 (vascular endothelium); COL18A1,
Collagen, type XVIII, α1; COL4A3, Collagen, type IV, α3 (Goodpasture antigen); CXCL10, Chemokine
(C-X-C motif) ligand 10; CXCL9, Chemokine (C-X-C motif) ligand 9; S1PR1, Sphingosine-1-phosphate
receptor 1; EGF, Epidermal growth factor; EREG, Epiregulin; FGFR3, fibroblast growth factor receptor 3;
FIGF, C-fos induced growth factor (vascular endothelial growth factor D); FLT1, Fms-related tyrosine kinase
1 (vascular endothelial growth factor/vascular permeability factor receptor); HAND2, Heart and neural crest
derivatives expressed 2; HGF, Hepatocyte growth factor (hepapoietin A; scatter factor); HPSE, Heparanase;
ID1, Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein; IFNA1, Interferon, α1; IFNB1,
Interferon, β1, fibroblast; IFNG, Interferon, γ; IGF1, Insulin-like growth factor 1 (somatomedin C); IL1B,
Interleukin 1, β; IL6, Interleukin 6 (interferon, β2); IL8, Interleukin 8; KDR, Kinase insert domain receptor (a
type III receptor tyrosine kinase); LAMA5, Laminin, α5; LECT1, Leukocyte cell derived chemotaxin 1; LEP,
Leptin; MMP2, Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase);
NOTCH4, Notch 4; PF4, Platelet factor 4; PGF, Placental growth factor; PLAU, Plasminogen activator,
urokinase; PLG, Plasminogen; PROK2, Prokineticin 2; PTGS1, Prostaglandin-endoperoxide synthase 1
(prostaglandin G/H synthase and cyclooxygenase); SPHK1, Sphingosine kinase 1; STAB1, Stabilin 1; TEK,
TEK tyrosine kinase, endothelial/Tie-2; TGFBR1 transforming growth factor, β receptor 1; TIMP1, TIMP
metallopeptidase inhibitor 1; TIMP3, TIMPmetallopeptidase inhibitor 3; TNF, Tumor necrosis factor;
TNFAIP2, Tumor necrosis factor, α-induced protein 2; VEGFA, Vascular endothelial growth factor A; VEGFC,
Vascular endothelial growth factor C.
doi:10.1371/journal.pone.0117530.g009
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Fig 10. CAF induced proliferation and resistance to apoptosis, decreased PBMC adhesion and
triggered in vitro angiogenesis of HUVECs cultured with uremic toxins. Proliferation (XTT-based assay
in A), resistance to apoptosis (TUNEL assay in B), PBMC adhesion (C) and in vitro angiogenesis on Matrigel
coated-plates (representative micrographs in D, count of capillary-like structures in E) of HUVECs cultured
with the uremic toxins ADMA (10 μg/ml), p-cresyl sulfate (1 μg/ml) and indoxyl sulfate (10 μg/ml) in presence
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or absence of CAF. Uremic toxins reduced cell viability, increased apoptosis and PBMC adhesion and
abrogated angiogenesis of HUVECs (#p< 0.05 Uremic Toxins vs. Vehicle). By contrast, increasing doses of
CAF (100 nM, 1μM, 10μM) increased viabilty and resistance to apoptosis (*p< 0.05 Uremic Toxins + CAF
100 nM, 1μM or 10μM vs. Uremic Toxins), and a fixed dose of CAF 1μM decreased PBMC adhesion and
triggered angiogenesis of uremic toxin-treated HUVECs (*p< 0.05 Uremic Toxins + CAF 1μM vs. Uremic
Toxins). Results are expressed as average±1SD of 3 different experiments.
doi:10.1371/journal.pone.0117530.g010
Fig 11. CAF reduced tubular cell injury and granulocyte infiltration in an experimental model of kidney
ischemia-reperfusion injury in C57BL-6mice. (A) Hematoxylin/eosin staining of representative kidney
sections from different experimental groups of C57BL-6 mice (n = 6 for each group): sham-operated (SHAM);
right kidney ischemia-reperfusion injury (IRI); right kidney ischemia-reperfusion injury + Caffeic acid 1μM/ml
(IRI + CAF). Original magnification was x40. Counts of TdT-mediated dUTP nick end labeling (TUNEL)-
positive cells (B) and of granulocyte infiltration (C) in the different experimental conditions. A significant
increase of apoptotic tubular cells and infiltrating granulocytes was observed in IRI in comparison with sham-
treated animals (#p<0.05 IRI vs. SHAM). CAF induced a significant decrease of apoptotic tubular cells and
granulocyte infiltration in mice subjected to IRI (*p<0.05 IRI + CAF vs. IRI). In B and C, results are expressed
as average±1SD in 30 non-consecutive fields.
doi:10.1371/journal.pone.0117530.g011
Caffeic Acid Modulates Nitric Oxide Production
PLOS ONE | DOI:10.1371/journal.pone.0117530 April 8, 2015 17 / 21
such as angiopoietin-1, EGF, FGF, HGF, IGF-1, IL-6, VEGF, MMP-2 and growth factor recep-
tors including FGF-R, Flt1 and KDR.
In conclusion, the results of the present study suggest that CAF-induced NO bioavaibility
and inhibition of ROS production may explain, at least in part, the potential endothelial protec-
tion associated with moderate white wine assumption typical of Mediterranean diet. The CAF-
induced inhibition of the inflammatory and apoptotic injury and the triggering of angiogenesis
of HUVECs may be responsible for a cardio-protective and reno-protective effect of this phe-
nol due to the limitation of oxidant stress-induced microvascular derangement in presence of
hypoxia and/or uremic toxins.
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